46 related articles for article (PubMed ID: 11126274)
1. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
Parks T; Wilson C; Curtis N; Norrby-Teglund A; Sriskandan S
Clin Infect Dis; 2018 Oct; 67(9):1434-1436. PubMed ID: 29788397
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for streptococcal toxic shock syndrome: systematic review and meta-analysis.
Bartoszko JJ; Elias Z; Rudziak P; Lo CKL; Thabane L; Mertz D; Loeb M
BMJ Open; 2022 Dec; 12(12):e063023. PubMed ID: 36456018
[TBL] [Abstract][Full Text] [Related]
3. Complement Inhibition and COVID-19: The Story so Far.
Fodil S; Annane D
Immunotargets Ther; 2021; 10():273-284. PubMed ID: 34345614
[TBL] [Abstract][Full Text] [Related]
4. Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis.
Mannes M; Schmidt CQ; Nilsson B; Ekdahl KN; Huber-Lang M
Semin Immunopathol; 2021 Dec; 43(6):773-788. PubMed ID: 34191093
[TBL] [Abstract][Full Text] [Related]
5. Successful use of daily intravenous infusion of C1 esterase inhibitor concentrate in the treatment of a hereditary angioedema patient with ascites, hypovolemic shock, sepsis, renal and respiratory failure.
Pham H; Santucci S; Yang WH
Allergy Asthma Clin Immunol; 2014; 10(1):62. PubMed ID: 25520740
[TBL] [Abstract][Full Text] [Related]
6. Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors.
Honda-Ogawa M; Ogawa T; Terao Y; Sumitomo T; Nakata M; Ikebe K; Maeda Y; Kawabata S
J Biol Chem; 2013 May; 288(22):15854-64. PubMed ID: 23589297
[TBL] [Abstract][Full Text] [Related]
7. The role of complement system in septic shock.
Charchaflieh J; Wei J; Labaze G; Hou YJ; Babarsh B; Stutz H; Lee H; Worah S; Zhang M
Clin Dev Immunol; 2012; 2012():407324. PubMed ID: 23049598
[TBL] [Abstract][Full Text] [Related]
8. Validation of C1-esterase inhibitor therapy in severe capillary leak syndrome by monitoring of extravascular lung water.
Kluge S; Kreymann G
Intensive Care Med; 2004 Apr; 30(4):731. PubMed ID: 14727019
[No Abstract] [Full Text] [Related]
9. Toxic shock syndrome in children: epidemiology, pathogenesis, and management.
Chuang YY; Huang YC; Lin TY
Paediatr Drugs; 2005; 7(1):11-25. PubMed ID: 15777108
[TBL] [Abstract][Full Text] [Related]
10. The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients.
Fronhoffs S; Luyken J; Steuer K; Hansis M; Vetter H; Walger P
Intensive Care Med; 2000 Oct; 26(10):1566-70. PubMed ID: 11126274
[TBL] [Abstract][Full Text] [Related]
11. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.
Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG
Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367
[TBL] [Abstract][Full Text] [Related]
12. C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction.
Caliezi C; Zeerleder S; Redondo M; Regli B; Rothen HU; Zürcher-Zenklusen R; Rieben R; Devay J; Hack CE; Lämmle B; Wuillemin WA
Crit Care Med; 2002 Aug; 30(8):1722-8. PubMed ID: 12163783
[TBL] [Abstract][Full Text] [Related]
13. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.
Hack CE; Ogilvie AC; Eisele B; Eerenberg AJ; Wagstaff J; Thijs LG
Intensive Care Med; 1993; 19 Suppl 1():S19-28. PubMed ID: 8053997
[TBL] [Abstract][Full Text] [Related]
14. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin.
Giebler R; Schmidt U; Koch S; Peters J; Scherer R
Crit Care Med; 1999 Mar; 27(3):597-604. PubMed ID: 10199542
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
